Biotech Leadership: The CEO–CMO Dynamic
About this episode
The episode discusses the critical relationship between CEOs and CMOs in early-stage biotechs and how it influences organizational growth and clarity.
In this conversation, Kim Kushner and Adriana Valenciano , Head of Client Delivery at SSI Strategy, take a closer look at what truly drives progress in early-stage biotechs. Picking up on themes first raised by Dr. Ed Tucker , they explore how leadership partnership, the structure of a Target Product Profile, and the intentional use of AI all shape how young organizations grow. In biotech’s earliest stages, the relationship between the CEO and Chief Medical Officer often determines whether a company builds momentum or stalls in misalignment. When these roles evolve together, sharing a view of how science, business, and culture intersect, the organization gains the clarity to move fast without losing direction. That clarity is reinforced by a strong Target Product Profile (TPP). More than a regulatory document, the TPP functions as a living blueprint that connects clinical strategy to company purpose. Used well, it aligns teams across functions, sets measurable targets for efficacy and value, and keeps both the scientific and organizational focus anchored to a shared definition of success. Innovation also depends on intentional design. With new AI tools transforming how work gets…
More episodes of The Emerging Biotech Leader
- Rethinking Trial Design for Rare Diseases
- Rare Disease Commercialization: Beyond Approval
- Clinical Operations as a Strategic Function
- How Clinical Operations Shapes Biotech Strategy
- 50 Episodes in: Lessons from The Emerging Biotech Leader
- From TPP to Teamwork: Creating Structure as a Biotech CMO
Explore listener stats, chart rankings, contacts and more on the The Emerging Biotech Leader podcast page.